Evidence map›Paper›PMID 31130623›Full record

ArticleInternational journal of molecular sciences2019

Experimental Motor Neuron Disease Induced in Mice with Long-Term Repeated Intraperitoneal Injections of Serum from ALS Patients.

Izabella Obál, Bernát Nógrádi, Valéria Meszlényi, Roland Patai, Gerda Ricken, Gabor G Kovacs, Kornélia Tripolszki, Márta Széll, László Siklós, József I Engelhardt

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. The presence and clinical significance of autoantibodies in amyotrophic lateral sclerosis: a narrative review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Modelling amyotrophic lateral sclerosis in rodents.Nature reviews. Neuroscience · 2022
    Review
  8. Article
  9. Where and Why Modeling Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Izabella ObálDepartment of Neurology, University of Szeged, H-6725 Szeged, Hungary. obalizabella@yahoo.com.
Bernát NógrádiDepartment of Neurology, University of Szeged, H-6725 Szeged, Hungary. bernatnogradi@gmail.com.ORCID 0000-0001-8643-0367
Valéria MeszlényiDepartment of Neurology, University of Szeged, H-6725 Szeged, Hungary. mesval13@gmail.com.
Roland PataiInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, H-6726 Szeged, Hungary. roland.patai.1988@gmail.com.ORCID 0000-0002-5302-2815
Gerda RickenClinical Institute of Neurology, Medical University of Vienna, Vienna A-1090, Austria. gerda.ricken@meduniwien.ac.at.ORCID 0000-0003-0388-7965
Gabor G KovacsClinical Institute of Neurology, Medical University of Vienna, Vienna A-1090, Austria. gabor.kovacs@meduniwien.ac.at.ORCID 0000-0003-3841-5511
Kornélia TripolszkiDepartment of Medical Genetics, University of Szeged, H-6720 Szeged, Hungary. tripolszki.kornelia@med.u-szeged.hu.
Márta SzéllDepartment of Medical Genetics, University of Szeged, H-6720 Szeged, Hungary. szell.marta@med.u-szeged.hu.
László SiklósInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, H-6726 Szeged, Hungary. siklos.laszlo@brc.mta.hu.
József I EngelhardtDepartment of Neurology, University of Szeged, H-6725 Szeged, Hungary. eji48dec9@yahoo.com.
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUMedical University of Vienna · AT

Funding

Ministry for the National Economy of Hungary GINOP-2.3.2-15-2016-00001Ministry for the National Economy of Hungary GINOP-2.3.2-15-2016-00034Ministry for the National Economy of Hungary GINOP-2.3.3.-15-2016-00001Ministry of Human Capacities 13725-2/2018/INTFINMinistry of Human Capacities NTP-NFTÖ-18-B-0208Ministry of Human Capacities UNKP-18-2
6 · The paper itself

Abstract

In an earlier study, signs of commencing degeneration of spinal motor neurons were induced in mice with short-term intraperitoneal injections of immunoglobulin G (IgG) taken from patients with amyotrophic lateral sclerosis (ALS). Since in that study, neither weakness nor loss of motor neurons was noted, to test whether the ALS IgG in this paradigm has the potential to evoke relentless degeneration of motor neurons, treatment with repeated injections over a longer period was carried out. Mice were systematically injected intraperitoneally with serum taken from ALS patients over a 75-day period. At selected time points, the isometric force of the limbs, number of spinal motor neurons and their intracellular calcium levels were determined. Furthermore, markers of glial activation and the motoneuronal uptake of human IgG were monitored. During this period, gliosis and progressive motoneuronal degeneration developed, which led to gradual loss of spinal motor neurons, more than 40% at day 21, along with decreasing muscle strength in the limbs. The inclusion-like accumulation of IgG appeared in the perikarya with the increase of intracellular calcium in the cell bodies and motor nerve terminals. Our results demonstrate that ALS serum can transfer motor neuron disease to mice.

Indexed as

Amyotrophic Lateral SclerosisAnimalsCalciumDisease Models, AnimalFemaleHumansImmunoglobulin GInjections, IntraperitonealMaleMiceMice, Inbred BALB CMotor Neuron DiseaseMotor NeuronsSerumCalciumImmunoglobulin GALSdegenerationIgG uptakeintracellular calciummotor neuronpassive transferserum

Identifiers

PMID31130623
PMCPMC6566871
OpenAlexW2946669328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.